六块爱理不理 8块高攀不起查看全文
格隆汇11月15日丨Aytu BioPharma(AYTU.US)盘前涨18.76%,报0.23美元。公司2023年Q1财报实现营收2765.5万美元,前值为2189.7万美元,预期值为2430万美元,超出市场预期13.81%;每股收益为-0.06美元,前值为-0.33美元,预期值为-0.18美元,超出市场预期66.67%。 网页链接
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-23-000135 Size: 7 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-23-072336 Act: 34 Size: 75 KB 网页链接
$Aytu BioPharma(AYTU)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0000935836-23-000462 Act: 34 Size: 60 KB 网页链接
$Aytu BioPharma(AYTU)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000912282-23-000133 Size: 5 KB 网页链接
$Aytu BioPharma(AYTU)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0000912282-23-000130 Size: 10 KB 网页链接
$Aytu BioPharma(AYTU)$ 8-K Current report, items 1.01, 5.02, 8.01, and 9.01 Accession Number: 0001104659-23-070444 Act: 34 Size: 269 KB 网页链接
$Aytu BioPharma(AYTU)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001104659-23-070432 Act: 33 Size: 426 KB 网页链接
$Aytu BioPharma(AYTU)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-23-069672 Act: 34 Size: 51 KB 网页链接
$Aytu BioPharma(AYTU)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-001685 Act: 33 Size: 1 KB 网页链接
$Aytu BioPharma(AYTU)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-23-068518 Act: 34 Size: 14 MB 网页链接